SONN - Sonnet BioTherapeutics Holdings, Inc.
1.26
-1.840 -146.032%
Share volume: 10,456,154
Last Updated: 12-02-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$3.10
-1.84
-0.59%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 02-13-2025 | 02-13-2025 | 05-13-2025 | 08-13-2025 | 12-16-2025 | |
| Cash flow financing | 41.000 K | 2.850 M | -234.705 K | 7.622 M | 0.000 | 21.050 K | 18.723 M | |
| Other financing cash flows | 0.000 | 2.932 M | -19.199 K | -88.868 K | 0.000 | 0.000 | 11.186 M | |
| Cash flow | 0.000 | -231.853 K | 0.000 | 4.712 M | 0.000 | 0.000 | 0.000 | |
| Net income | 365.425 K | -3.506 M | -3.129 M | 0.000 | -3.491 M | -3.776 M | 0.000 | |
| Depreciation | 3.211 K | 3.211 K | 3.210 K | 3.211 K | 0.000 | 1.948 K | 1.948 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -12.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 764.792 K | -231.853 K | -3.405 M | 4.712 M | 0.000 | -1.738 M | 13.036 M |